Transparency of clinical trials in pancreatic cancer: An analysis of availability of trial results from the ClinicalTrials.gov database
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Pancreatic cancer (PC) is a highly malignant tumor of the digestive system. As clinical trials involving PC are increasingly being conducted, the transparency of the generated data has become an important issue of concern. In other areas of medicine, clinical trial transparency presents a worrying state of affairs. However, at present, there has been no study examining the transparency of data derived from PC clinical trials. Methods: A comprehensive search was conducted in the ClinicalTrial.gov database for clinical trials investigating pancreatic cancer as of June 2022. We examined the availability of clinical trial results and recorded the characteristics of the trials. Results: A total of 856 trials were included in this study, of which 668 were completed and 188 were terminated or suspended. The results of 626 trials (73.13%) were available, of these 230 trials (26.87%) did not disclose any information on the trial data in any form. The publication rate for trials with available results was 86.10%, but the report rate on ClinicalTrial.gov was only 39.78%. Conclusion: Although approximately 90% of clinical trial investigating interventions on patients with PC have published study results, 30% of trials did not report any findings, and the disclosure of trial results from ClinicalTrial.gov was unsatisfactory. In general, there is still room for improvement in the transparency of PC clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These functions are particularly relevant to clinical trials and research governance, where transparency, protocol adherence, and accountability remain persistent concerns [54,55].”
From Blockchain for Digital Health Governance: Evidence Gap Map and Scoping Review (2026) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimated Projection of US Cancer Incidence and Death to 2040
Rahib, L., Wehner, M. R., Matrisian, L. M., & Nead, K. T. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.4708 · Cited by 1,339 · cited 1×
“In the United States, PC ranks fourth in malignancy-related deaths, while in China, PC ranks sixth (11, 12).”
BackgroundPancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors
Klein, A. P. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00457-x · Cited by 1,258
The ClinicalTrials.gov Results Database — Update and Key Issues
Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1012065 · Cited by 838
Research works printed but not linked: 19
- Zarin, 2007, Issues in the registration of clinical trials, Jama., 297, 10.1001/jama.297.19.2112 · DOI · Paper page
- Dal-Re, 2015, Improving transparency of clinical trials, Trends Pharmacol Sci, 36, 10.1016/j.tips.2014.10.012 · DOI
- Saito, 2014, How frequently do the results from completed US clinical trials enter the public domain, –A Stat Anal ClinicalTrials.gov database. PloS One, 9, 10.1371/journal.pone.0101826 · DOI · Paper page
- Dal-Ré, 2016, Prevention of selective outcome reporting: let us start from the beginning, Eur J Clin Pharmacol, 72, 10.1007/s00228-016-2112-3 · DOI
- Garg, 2022, Gastroenterology clinical trials transparency: An analysis of publication rates from the ClinicalTrials, gov Database. Am J Gastroenterol, 117, 10.14309/ajg.0000000000001517 · DOI
- Garg, 2022, Clinical trial transparency in gastrointestinal endoscopy research, Endoscopy., 55, 36, 10.1055/a-1855-7870 · DOI
- Rahib, 2014, Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the united states, Cancer Res, 74, 10.1158/0008-5472.CAN-14-0155 · DOI · Paper page
- Moore, 2019, Pancreatic cancer, Jama., 322, 1426, 10.1001/jama.2019.14699 · DOI
- Chen, 2016, Cancer statistics in China, 2015, CA: Cancer J Clin, 66, 10.3322/caac.21338 · DOI · Paper page
- Janssen, 2022, Neoadjuvant radiotherapy after (m)FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: A TAPS consortium study, J Natl Compr Cancer Network JNCCN., 20, 783, 10.6004/jnccn.2022.7008 · DOI
- Pion, 2022, 3D in vivo models for translational research on pancreatic cancer: The chorioallantoic membrane (CAM) model, Cancers., 14, 10.3390/cancers14153733 · DOI
- Chuong, 2022, Induction chemotherapy and ablative stereotactic magnetic resonance image-guided adaptive radiation therapy for inoperable pancreas cancer, Front Oncol, 12, 10.3389/fonc.2022.888462 · DOI
- Uson Junior, 2022, Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: A contemporary analysis, Sci Rep, 12, 13592, 10.1038/s41598-022-17743-6 · DOI
- Pranić, 2016, Changes to registration elements and results in a cohort of clinicaltrials.gov trials were not reflected in published Articles, J Clin Epidemiol, 70, 26, 10.1016/j.jclinepi.2015.07.007 · DOI
- Huić, 2011, Completeness and changes in registered data and reporting bias of randomized controlled trials in ICMJE journals after trial registration policy, PloS One, 6, 10.1371/journal.pone.0025258 · DOI · Paper page
- Roberto, 2018, Transparency in ovarian cancer clinical trial results: ClinicalTrials.gov versus PubMed, embase and Google scholar, J Ovarian Res, 11, 28, 10.1186/s13048-018-0404-1 · DOI
- Nguyen, 2013, Public availability of results of trials assessing cancer drugs in the united states, J Clin Oncol Off J Am Soc Clin Oncol, 31, 2998, 10.1200/JCO.2012.46.9577 · DOI · Paper page
- Tempero, 2021, Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology, J Natl Compr Cancer Network JNCCN, 19, 10.6004/jnccn.2021.0017 · DOI · Paper page
- Okusaka, 2020, Recent advances in chemotherapy for pancreatic cancer: Evidence from Japan and recommendations in guidelines, J gastroenterology., 55, 10.1007/s00535-020-01666-y · DOI
Cited by
Blockchain for Digital Health Governance: Evidence Gap Map and Scoping Review
Yaghobian, S., Sulkowski, N., Galambos, G., Scarazzini, L., Maloumian, N., & Verhaeghe, S. (2026) · Journal of Medical Internet Research · doi:10.2196/96098 · Cited by 1
Metadata
- Authors
- Huang, R.-Q., Zhou, Y., Zheng, H.-X., Wang, D., Zheng, X.-Y., Li, Z.-S., & Hu, L.-H.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2023-01-06
- Volume
- 12
- ISSN
- 2234-943X
- Cited by
- 6
- References
- 3
- Funders
- National Natural Science Foundation of China (No. 82070664)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.